Chimera Investment Stock-Based Compensation Growth & History (CIM)
Chimera Investment's stock-based compensation was $9.7M for fiscal 2025.
View full Chimera Investment company overviewChimera Investment annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.7M | −$401,000 | −3.97% |
| 2024 | 2024-12-31 | $10.1M | $543,000 | +5.68% |
| 2023 | 2023-12-31 | $9.6M | $1.4M | +16.82% |
| 2022 | 2022-12-31 | $8.2M | $1.7M | +25.55% |
| 2021 | 2021-12-31 | $6.5M | $1.5M | +29.82% |
| 2020 | 2020-12-31 | $5.0M | −$5.6M | −52.60% |
| 2019 | 2019-12-31 | $10.6M | $1.8M | +20.31% |
| 2018 | 2018-12-31 | $8.8M | $4.8M | +119.92% |
| 2017 | 2017-12-31 | $4.0M | $2.0M | +100.00% |
| 2016 | 2016-12-31 | $2.0M | $1.0M | +100.00% |
| 2015 | 2015-12-31 | $1.0M | $834,000 | +502.41% |
| 2014 | 2014-12-31 | $166,000 | — | — |
Chimera Investment quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.0M | $810,000 | +37.80% |
| Q1 2026 | 2026-03-31 | $2.7M | −$1.0M | −27.17% |
| Q4 2025 | 2025-12-31 | $1.7M | $215,000 | +14.63% |
| Q3 2025 | 2025-09-30 | $2.1M | −$1.1M | −34.01% |
| Q2 2025 | 2025-06-30 | $2.1M | −$283,000 | −11.67% |
| Q1 2025 | 2025-03-31 | $3.7M | $761,000 | +25.52% |
| Q4 2024 | 2024-12-31 | $1.5M | −$1.6M | −52.78% |
| Q3 2024 | 2024-09-30 | $3.2M | $886,000 | +38.01% |
| Q2 2024 | 2024-06-30 | $2.4M | $736,000 | +43.55% |
| Q1 2024 | 2024-03-31 | $3.0M | $564,000 | +23.33% |
| Q4 2023 | 2023-12-31 | $3.1M | −$333,000 | −9.66% |
| Q3 2023 | 2023-09-30 | $2.3M | −$8,000 | −0.34% |
| Q2 2023 | 2023-06-30 | $1.7M | $593,000 | +54.06% |
| Q1 2023 | 2023-03-31 | $2.4M | $1.1M | +86.72% |
| Q4 2022 | 2022-12-31 | $3.4M | — | — |
| Q3 2022 | 2022-09-30 | $2.3M | $339,000 | +16.95% |
| Q2 2022 | 2022-06-30 | $1.1M | −$812,000 | −42.54% |
| Q1 2022 | 2022-03-31 | $1.3M | −$2.8M | −68.09% |
| Q3 2021 | 2021-09-30 | $2.0M | $422,000 | +26.74% |
| Q2 2021 | 2021-06-30 | $1.9M | $518,000 | +37.24% |
| Q1 2021 | 2021-03-31 | $4.1M | $2.9M | +255.03% |
| Q4 2020 | 2020-12-31 | $905,000 | — | — |
| Q3 2020 | 2020-09-30 | $1.6M | −$1.1M | −41.99% |
| Q2 2020 | 2020-06-30 | $1.4M | −$1.6M | −53.63% |
| Q1 2020 | 2020-03-31 | $1.1M | −$3.9M | −77.14% |
| Q3 2019 | 2019-09-30 | $2.7M | $720,000 | +36.00% |
| Q2 2019 | 2019-06-30 | $3.0M | $1.0M | +50.00% |
| Q1 2019 | 2019-03-31 | $5.0M | $3.0M | +150.00% |
| Q4 2018 | 2018-12-31 | $2.8M | $1.8M | +179.70% |
| Q3 2018 | 2018-09-30 | $2.0M | $1.0M | +100.00% |
| Q2 2018 | 2018-06-30 | $2.0M | $1.0M | +100.00% |
| Q1 2018 | 2018-03-31 | $2.0M | $1.0M | +100.00% |
| Q4 2017 | 2017-12-31 | $1.0M | $374,000 | +59.74% |
| Q3 2017 | 2017-09-30 | $1.0M | $380,000 | +61.29% |
| Q2 2017 | 2017-06-30 | $1.0M | $348,000 | +53.37% |
| Q1 2017 | 2017-03-31 | $1.0M | $898,000 | +880.39% |
| Q4 2016 | 2016-12-31 | $626,000 | $549,000 | +712.99% |
| Q3 2016 | 2016-09-30 | $620,000 | $169,000 | +37.47% |
| Q2 2016 | 2016-06-30 | $652,000 | $616,000 | +1711.11% |
| Q1 2016 | 2016-03-31 | $102,000 | −$334,000 | −76.61% |
| Q4 2015 | 2015-12-31 | $77,000 | — | — |
| Q3 2015 | 2015-09-30 | $451,000 | — | — |
| Q2 2015 | 2015-06-30 | $36,000 | — | — |
| Q1 2015 | 2015-03-31 | $436,000 | — | — |
Chimera Investment stock-based compensation trends
Over the last five fiscal years, Chimera Investment's stock-based compensation increased from $5.0M to $9.7M, a change of $4.7M. The latest reported quarter, Q2 2026, shows $3.0M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chimera Investment source filings ↗